|
|
Information on |
|
|
Chongqing Pharmaceutical Research Institute Co., Ltd. |
| Company Type: Leading producer |
Integrated API Services Provider
Founded in 1950s, Chongqing Pharmaceutical Research Institute Co., Ltd (CPRI) is an R&D-based company providing integrated generic API services from early-stage development to commercialization with its expertise in non-infringing process development and cGMP manufacture.
CPRI provide:
- Full-scale cGMP manufacture of APIs & advanced intermediates
- Contract research for generic APIs and FDF
- Contract manufacture for hard-to-find APIs
CPRI have 3 manufacture sites:
- CPRI Tushan Road Site, cGMP,US FDA approved
- CPRI Changshou Site, cGMP,under construction
- Kangle Pharma Site, GMP
CPRI strength lies in polymorph study, analytical R&D for small and HMW compounds, IP analysis and process development.
History: Founded in 1950s, previously well known as the state-owned Chongqing Pharmaceutical Research Institute, CPRI was one of the pioneers involved in drug R&D and cGMP-compliant API manufacturing in China. In 1994, generic API of Clindamycin HCl was approved by US FDA. Now, CPRI is a subsidiary of FOSUN Pharmaceutical (Group), Co., Ltd, which is a leading pharmaceutical company in China.
Faculty and Facility: R&D and quality management are well supported with the latest method of pharmaceutical analysis and the most advanced equipment including GC, LC/MS, HPLCs, UV, etc. which are all made in USA or German. Moreover, the capable and well-qualified CPRI personnel often surprise the visitors who visited the company.
Location: CPRI is located in Chongqing, the most prosperous and promising magacity in China, the fourth municipality with the largest population of 32 million. |
|
| Address |
Chongqing Pharmaceutical Research Institute Co., Ltd.
No.565, Tushan Road, Nanan Disctrict
Chongqing 400061, P.R.China
|
| Phone |
+86-23-62504026 |
| Fax |
+86-23-62512066 |
| |
send an inquiry |
| Sales contact |
Ms. Li |
|
|
|
|
|
|
